Hudrisier D, Riond J, Gairin J E
Laboratoire d'ImmunoPharmacologie Structurale, Institut de Pharmacologie et de Biologie Structurale, CNRS, 31400 Toulouse, France.
J Virol. 2001 Mar;75(5):2468-71. doi: 10.1128/JVI.75.5.2468-2471.2001.
Infection of H-2b mice with lymphocytic choriomeningitis virus (LCMV) generates an H-2Db-restricted cytotoxic T-lymphocyte (CTL) response whose subdominant component is directed against the GP92-101 (CSANNSHHYI) epitope. The aim of this study was to identify the functional parameters accounting for this subdominance. We found that the two naturally occurring (genetically encoded and posttranslationally modified) forms of LCMV GP92-101 were immunogenic, did not act as T-cell antagonists, and bound efficiently to but were unable to form stable complexes with H-2Db, a crucial factor for immunodominance. Thus, the H-2Db-restricted subdominant CTL response to LCMV resulted not from altered T-cell activation but from impaired major histocompatibility complex presentation properties.
用淋巴细胞性脉络丛脑膜炎病毒(LCMV)感染H-2b小鼠会产生一种受H-2Db限制的细胞毒性T淋巴细胞(CTL)反应,其次要成分针对GP92-101(CSANNSHHYI)表位。本研究的目的是确定导致这种次要性的功能参数。我们发现,LCMV GP92-101的两种天然存在形式(基因编码和翻译后修饰)具有免疫原性,不是T细胞拮抗剂,能有效结合H-2Db但无法与之形成稳定复合物,而这是免疫显性的关键因素。因此,针对LCMV的H-2Db限制的次要CTL反应并非源于T细胞激活改变,而是源于主要组织相容性复合体呈递特性受损。